PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration
Maciej Zieliński, Justyna Sakowska, Dorota Iwaszkiewicz‐Grześ, Mateusz Gliwiński, Matylda Hennig, Magdalena Żalińska, Anna Wołoszyn‐Durkiewicz, Anna Jaźwińska-Curyłło, Halla Kamińska, Radosław Owczuk, Wojciech Młynarski, Przemysława Jarosz‐Chobot, Artur Bossowski, Agnieszka Szadkowska, Wojciech Fendler, Iwona Beń‐Skowronek, Agata Chobot, Małgorzata Myśliwiec, Janusz Siebert, Natalia Marek-Trzonkowska, Piotr Trzonkowski
Topics & Concepts
FOXP3IL-2 receptorImmunologyCD8ImmunotherapyMedicineT cellRegulatory T cellCD20Cytotoxic T cellAntigenInternal medicineBiologyImmune systemIn vitroBiochemistryImmune Cell Function and InteractionDiabetes and associated disordersT-cell and B-cell Immunology